Description: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China.
Home Page: www.zhongxinp.com
Zhong Xin Mansion
Tianjin,
300193
China
Phone:
86 22 2702 0892
Officers
Name | Title |
---|---|
Ms. Niu Shengfang | Deputy GM & Deputy Chief Accountant |
Mr. Jian Zhang | Deputy Gen. Mang. |
Ms. Xin Wang | Deputy Gen. Mang. |
Ms. Lei Wang | Gen. Mang. |
Mr. Hong Zhou | Deputy GM, Chief Engineer & Exec. Director |
Mr. Mai Wang | Employee Director and Chairman of the Union & Director of the organization department |
Mr. Min Guo | Exec. Director |
Mr. Yu Zhang | Chief Production Officer |
Ms. Yan Jiao | Sec. to the Board of Directors |
Exchange: STU
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 10.92 |
Price-to-Book MRQ: | 1.6272 |
Price-to-Sales TTM: | 0.3153 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 4913 |